Insights
61 articles
Informative Introduction Effective communication is the backbone of a successful Pharmacovigilance (PV) system. Whether managing safety data, coordinating with vendors, supporting clients, or responding to competent authorities, clear…
Pharmacovigilance (PV) inspections are critical checkpoints in ensuring the safety of medicines and the integrity of post-marketing surveillance systems. Conducted by regulatory authorities and national competent authorities, these…
A Pharmacovigilance Agreement is a legally binding document that clearly defines how safety information will be collected, assessed, exchanged, and reported between partners throughout the product’s life cycle.…
In recent years, the significance of pharmacovigilance (PV) has grown dramatically, and the Ministry of Health and Prevention (MOHAP) of the United Arab Emirates (UAE) has reinforced its…
Pharmacovigilance (PV) in the United States plays a crucial role in ensuring the ongoing safety and efficacy of medicinal products. Unlike the European Union, where Good Pharmacovigilance Practices…
Pharmacovigilance (PV) in Russia is a critical component of the national healthcare system, designed to ensure the safety, efficacy, and quality of medicines throughout their lifecycle. Governed by…
In today’s global pharmaceutical landscape, Risk Management Plans (RMPs) are cornerstone documents ensuring that the benefits of medicinal products outweigh their risks. They serve as living frameworks for…
In pharmacovigilance, Local Safety Databases (LSDs) are critical for ensuring continuous monitoring of drug safety within specific countries or regions. While the WHO’s VigiBase serves as a global…
Pharmacovigilance (PV) in China refers to the scientific and regulatory activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The…
PV Requirements in Latin American Countries (Brazil, Mexico, Argentina, Chile, and Colombia) Introduction Medicines don’t stop being monitored once they’re approved—they enter a new phase of oversight known…
The Pharmacovigilance System Master File (PSMF) serves as a cornerstone document within pharmacovigilance systems, providing a detailed overview of a company’s PV activities and organizational structures. While the…
In Greece, pharmacovigilance (PV) activities are regulated and supervised by the National Organization for Medicines (EOF – Εθνικός Οργανισμός Φαρμάκων). The requirements are aligned with EU legislation, but…
Modern pharmacovigilance monitors the safety of medicines throughout their life‑cycle and is essential for protecting public health. Safety signal detection refers to identifying patterns in data that suggest…
Although Australia and New Zealand are geographically close-to the point mistakenly considered to be one country-their pharmacovigilance (PV) systems are governed by different frameworks and guidelines. This article…
In the pharmaceutical world, ensuring patient safety is a global priority, and the Qualified Person for Pharmacovigilance (QPPV) plays a central role in this mission. However, regulatory frameworks…
Talk to our experts and get tailored solutions to help you stay compliant and move forward with confidence.
Submit RFI/RFP
Request Consultation
Submit RFI/RFP